Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1015

1.

A predictive model for survival after liver resection for noncolorectal liver metastases in the modern era: A Japanese multicenter analysis.

Wakabayashi T, Hibi T, Yoneda G, Iwao Y, Sawada Y, Hoshino H, Uemura S, Ban D, Kudo A, Takemura Y, Mishima K, Shinoda M, Itano O, Otsubo T, Endo I, Kitagawa Y, Tanabe M, Egawa H, Yamamoto M.

J Hepatobiliary Pancreat Sci. 2019 Jul 4. doi: 10.1002/jhbp.654. [Epub ahead of print]

PMID:
31271511
2.

Erratum: Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis.

Shinzaki S, Matsuoka K, Iijima H, Mizuno S, Serada S, Fujimoto M, Arai N, Koyama N, Morii E, Watanabe M, Hibi T, Kanai T, Takehara T, Naka T.

J Crohns Colitis. 2019 Jun 13. pii: jjz100. doi: 10.1093/ecco-jcc/jjz100. [Epub ahead of print] No abstract available.

PMID:
31222277
3.

Efficacy of repeated balloon venoplasty for treatment of hepatic venous outflow obstruction after pediatric living-donor liver transplantation: A single-institution experience.

Shimata K, Sugawara Y, Honda M, Ikeda O, Tamura Y, Hayashida S, Ohya Y, Yamamoto H, Yamashita Y, Inomata Y, Hibi T.

Pediatr Transplant. 2019 Jun 18:e13522. doi: 10.1111/petr.13522. [Epub ahead of print]

PMID:
31210388
4.

A Patient with KL-6 Elevation with Anti-TNFα Who Could Receive Long-Term Use without Interstitial Pneumonia after Class Switch of Anti-TNFα.

Masuda T, Yoshida A, Ueno F, Hara S, Nabeta H, Umezawa S, Shirai M, Morikawa Y, Morizane T, Endo Y, Hibi T.

Inflamm Intest Dis. 2019 May;4(1):35-40. doi: 10.1159/000497778. Epub 2019 Mar 25.

5.

Living Donor Liver Transplantation With a Left Trisection Plus Caudate Lobe Graft.

Ibuki S, Abe Y, Shimata K, Narita Y, Irie T, Yamamoto H, Sugawara Y, Hibi T.

Liver Transpl. 2019 Jun 4. doi: 10.1002/lt.25577. [Epub ahead of print] No abstract available.

PMID:
31162780
6.

Single-center Experience of Living-donor Liver Transplantation in Patients Receiving Maintenance Renal Replacement Therapy.

Irie T, Sugawara Y, Narita Y, Ibuki S, Shimata K, Yamamoto H, Hibi T.

Transplant Proc. 2019 Jun;51(5):1520-1521. doi: 10.1016/j.transproceed.2019.01.121.

PMID:
31155186
7.

Living Donor Liver Re-Transplantation for Recurrent Hepatoblastoma in the Liver Graft following Complete Eradication of Peritoneal Metastases under Indocyanine Green Fluorescence Imaging.

Takahashi N, Yamada Y, Hoshino K, Kawaida M, Mori T, Abe K, Fujimura T, Matsubara K, Hibi T, Shinoda M, Obara H, Isshiki K, Shima H, Shimada H, Kameyama K, Fuchimoto Y, Kitagawa Y, Kuroda T.

Cancers (Basel). 2019 May 26;11(5). pii: E730. doi: 10.3390/cancers11050730.

8.

Adverse events in patients with ulcerative colitis treated with indigo naturalis: a Japanese nationwide survey.

Naganuma M, Sugimoto S, Suzuki H, Matsuno Y, Araki T, Shimizu H, Hayashi R, Fukuda T, Nakamoto N, Iijima H, Nakamura S, Kataoka M, Tamura Y, Tatsumi K, Hibi T, Suzuki Y, Kanai T; INDIGO survey Group.

J Gastroenterol. 2019 May 17. doi: 10.1007/s00535-019-01591-9. [Epub ahead of print]

PMID:
31102012
9.

Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes.

Hayasaki A, Murata Y, Usui M, Hibi T, Fujii T, Iizawa Y, Kato H, Tanemura A, Azumi Y, Kuriyama N, Kishiwada M, Mizuno S, Sakurai H, Uchida K, Isaji S.

Biomed Res Int. 2019 Apr 4;2019:5738614. doi: 10.1155/2019/5738614. eCollection 2019.

10.

Withdrawal of thiopurines in Crohn's disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2).

Hisamatsu T, Kato S, Kunisaki R, Matsuura M, Nagahori M, Motoya S, Esaki M, Fukata N, Inoue S, Sugaya T, Sakuraba H, Hirai F, Watanabe K, Kanai T, Naganuma M, Nakase H, Suzuki Y, Watanabe M, Hibi T, Nojima M, Matsumoto T; DIAMOND2 Study Group.

J Gastroenterol. 2019 Apr 30. doi: 10.1007/s00535-019-01582-w. [Epub ahead of print]

PMID:
31041545
11.

Myelopathy due to human T-cell leukemia virus type-1 from the donor after ABO-incompatible liver transplantation.

Wakabayashi T, Obara H, Seki M, Shinoda M, Kitago M, Yagi H, Abe Y, Matsubara K, Yamada Y, Oshima G, Oki K, Nagoshi N, Watanabe K, Hibi T, Itano O, Hoshino K, Suzuki N, Kuroda T, Kitagawa Y.

Ann Hepatol. 2019 Mar - Apr;18(2):397-401. doi: 10.1016/j.aohep.2018.06.002. Epub 2019 Apr 17.

12.

Portal Vein Stent Placement in Living-donor Liver Transplantation: A Single-center Experience.

Narita Y, Sugawara Y, Ibuki S, Irie T, Shimata K, Yamamoto H, Hibi T.

Transplant Proc. 2019 Jun;51(5):1522-1524. doi: 10.1016/j.transproceed.2019.01.123. Epub 2019 Apr 19.

PMID:
31010697
13.

Living donor liver transplantation for a patient with a history of total gastrectomy.

Shimata K, Irie T, Kadohisa M, Kawabata S, Ibuki S, Narita Y, Yamamoto H, Sugawara Y, Hibi T.

Biosci Trends. 2019 May 12;13(2):212-215. doi: 10.5582/bst.2019.01037. Epub 2019 Apr 15.

14.

Correction: Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study.

Motoya S, Watanabe K, Ogata H, Kanai T, Matsui T, Suzuki Y, Shikamura M, Sugiura K, Oda K, Hori T, Araki T, Watanabe M, Hibi T.

PLoS One. 2019 Apr 11;14(4):e0215491. doi: 10.1371/journal.pone.0215491. eCollection 2019.

15.

Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study.

Motoya S, Watanabe K, Ogata H, Kanai T, Matsui T, Suzuki Y, Shikamura M, Sugiura K, Oda K, Hori T, Araki T, Watanabe M, Hibi T.

PLoS One. 2019 Feb 26;14(2):e0212989. doi: 10.1371/journal.pone.0212989. eCollection 2019. Erratum in: PLoS One. 2019 Apr 11;14(4):e0215491.

16.

Combination of colonoscopy and magnetic resonance enterography is more useful for clinical decision making than colonoscopy alone in patients with complicated Crohn's disease.

Sagami S, Kobayashi T, Kikkawa N, Umeda S, Nakano M, Toyonaga T, Okabayashi S, Ozaki R, Hibi T.

PLoS One. 2019 Feb 20;14(2):e0212404. doi: 10.1371/journal.pone.0212404. eCollection 2019.

17.

Efficacy of biological drugs in short-duration versus long-duration inflammatory bowel disease: a protocol for a systematic review and an individual-patient level meta-analysis of randomised controlled trials.

Ben-Horin S, Zhao Y, Guo J, Mao R, Novack L, Sergienko R, Zhang J, Kobayashi T, Hibi T, Chowers Y, Colombel JF, Peyrin-Biroulet L, Kaplan G, Chen MH.

BMJ Open. 2019 Jan 25;9(1):e024222. doi: 10.1136/bmjopen-2018-024222.

18.

Concerns and side effects of azathioprine during adalimumab induction and maintenance therapy for Japanese patients with Crohn's disease: a sub-analysis of a prospective randomized clinical trial (DIAMOND study).

Hisamatsu T, Matsumoto T, Watanabe K, Nakase H, Motoya S, Yoshimura N, Ishida T, Kato S, Nakagawa T, Esaki M, Nagahori M, Matsui T, Naito Y, Kanai T, Suzuki Y, Nojima M, Watanabe M, Hibi T; DIAMOND study group.

J Crohns Colitis. 2019 Feb 8. doi: 10.1093/ecco-jcc/jjz030. [Epub ahead of print]

PMID:
30753377
19.

Efficacy and safety of abrilumab, an α4β7 integrin inhibitor, in Japanese patients with moderate-to-severe ulcerative colitis: a phase II study.

Hibi T, Motoya S, Ashida T, Sai S, Sameshima Y, Nakamura S, Maemoto A, Nii M, Sullivan BA, Gasser RA, Suzuki Y.

Intest Res. 2019 Feb 12. doi: 10.5217/ir.2018.00141. [Epub ahead of print]

20.

Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation.

Uto K, Sakamoto S, Que W, Shimata K, Hashimoto S, Sakisaka M, Narita Y, Yoshii D, Zhong L, Komohara Y, Li XK, Inomata Y, Hibi T.

BMC Gastroenterol. 2019 Feb 8;19(1):25. doi: 10.1186/s12876-019-0939-7.

21.

The Burden of Diverticular Disease and Its Complications: West versus East.

Imaeda H, Hibi T.

Inflamm Intest Dis. 2018 Dec;3(2):61-68. doi: 10.1159/000492178. Epub 2018 Aug 7. Review.

22.

Individualized treatment based on CYP3A5 single-nucleotide polymorphisms with tacrolimus in ulcerative colitis.

Okabayashi S, Kobayashi T, Saito E, Toyonaga T, Ozaki R, Sagami S, Nakano M, Tanaka J, Yagisawa K, Kuronuma S, Takeuchi O, Hibi T.

Intest Res. 2019 Apr;17(2):218-226. doi: 10.5217/ir.2018.00117. Epub 2019 Feb 7.

23.

Decreased Incidence of Acute Cellular Rejection in Low-Muscle-Mass Recipients After Living-donor Liver Transplantation.

Wakabayashi T, Shinoda M, Obara H, Kitago M, Yagi H, Abe Y, Matsubara K, Yamada Y, Oshima G, Hirukawa K, Mizota T, Hibi T, Itano O, Hoshino K, Kuroda T, Kitagawa Y.

Transplant Proc. 2018 Dec;50(10):3626-3634. doi: 10.1016/j.transproceed.2018.06.028. Epub 2018 Jun 30.

PMID:
30577248
24.

Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients.

Yagisawa K, Kobayashi T, Ozaki R, Okabayashi S, Toyonaga T, Miura M, Hayashida M, Saito E, Nakano M, Matsubara H, Hisamatsu T, Hibi T.

Intest Res. 2019 Jan;17(1):87-93. doi: 10.5217/ir.2018.00078. Epub 2018 Dec 14.

25.

Crystal structure analysis and enzymatic characterization of γ-glutamyltranspeptidase from Pseudomonas nitroreducens.

Hibi T, Imaoka M, Shimizu Y, Itoh T, Wakayama M.

Biosci Biotechnol Biochem. 2019 Feb;83(2):262-269. doi: 10.1080/09168451.2018.1547104. Epub 2018 Dec 3.

PMID:
30507352
26.

Drug Lag for Inflammatory Bowel Disease Treatments in the East and West.

Okabayashi S, Kobayashi T, Hibi T.

Inflamm Intest Dis. 2018 Nov;3(1):25-31. doi: 10.1159/000491878. Epub 2018 Oct 5.

27.

Prevention of Infectious Diseases due to Immunosuppression and Vaccinations in Asian Patients with Inflammatory Bowel Disease.

Sagami S, Kobayashi T, Hibi T.

Inflamm Intest Dis. 2018 Nov;3(1):1-10. doi: 10.1159/000489643. Epub 2018 Jul 17. Review.

28.
29.

X-ray crystallographic analysis of the catalytic domain of α-1,3-glucanase FH1 from Paenibacillus glycanilyticus overexpressed in Brevibacillus choshinensis.

Intuy R, Itoh T, Suyotha W, Hayashi J, Yano S, Makabe K, Wakayama M, Hibi T.

Acta Crystallogr F Struct Biol Commun. 2018 Dec 1;74(Pt 12):770-773. doi: 10.1107/S2053230X18013109. Epub 2018 Nov 16.

PMID:
30511670
30.

Multicenter, retrospective, comparative study of laparoscopic and open Kasai portoenterostomy in children with biliary atresia from Japanese high-volume centers.

Murase N, Hinoki A, Shirota C, Tomita H, Shimojima N, Sasaki H, Nio M, Tahara K, Kanamori Y, Shinkai M, Yamamoto H, Sugawara Y, Hibi T, Ishimaru T, Kawashima H, Koga H, Yamataka A, Uchida H.

J Hepatobiliary Pancreat Sci. 2019 Jan;26(1):43-50. doi: 10.1002/jhbp.594. Epub 2019 Jan 12.

PMID:
30488647
31.

What is transplant oncology?

Hibi T, Sapisochin G.

Surgery. 2019 Feb;165(2):281-285. doi: 10.1016/j.surg.2018.10.024. Epub 2018 Nov 22. Review. No abstract available.

PMID:
30471780
32.

[Pulmonary tuberculosis following anti-tumor necrosis factor-α therapy in Crohn's disease:a case report].

Hara Y, Kobayashi T, Okabayashi S, Nakano M, Sagami S, Ozaki R, Nakayama S, Suzuki Y, Tsunematsu S, Hibi T.

Nihon Shokakibyo Gakkai Zasshi. 2018;115(11):996-1003. doi: 10.11405/nisshoshi.115.996. Japanese.

PMID:
30416161
33.

Liver Fibrosis Markers Improve Prediction of Outcome in Non-Acetaminophen-Associated Acute Liver Failure.

Ugamura A, Chu PS, Nakamoto N, Taniki N, Ojiro K, Hibi T, Shinoda M, Obara H, Masugi Y, Yamaguchi A, Shiba S, Morikawa R, Usui S, Ebinuma H, Kitagawa Y, Saito H, Kanai T.

Hepatol Commun. 2018 Sep 21;2(11):1331-1343. doi: 10.1002/hep4.1233. eCollection 2018 Nov.

34.

A Pre-Clinical Large Animal Model of Sustained Liver Injury and Regeneration Stimulus.

Inomata K, Tajima K, Yagi H, Higashi H, Shimoda H, Matsubara K, Hibi T, Abe Y, Tsujikawa H, Kitago M, Shinoda M, Obara H, Itano O, Soto-Gutierrez A, Kitagawa Y.

Sci Rep. 2018 Oct 9;8(1):14987. doi: 10.1038/s41598-018-32889-y.

35.

5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis.

Miyoshi J, Matsuoka K, Yoshida A, Naganuma M, Hisamatsu T, Yajima T, Inoue N, Okamoto S, Iwao Y, Ogata H, Ueno F, Hibi T, Kanai T.

Intest Res. 2018 Oct;16(4):635-640. doi: 10.5217/ir.2018.00015. Epub 2018 Oct 10.

36.

Seven days triple therapy for eradication of Helicobacter pylori does not alter the disease activity of patients with inflammatory bowel disease.

Shinzaki S, Fujii T, Bamba S, Ogawa M, Kobayashi T, Oshita M, Tanaka H, Ozeki K, Takahashi S, Kitamoto H, Kani K, Nanjo S, Sugaya T, Sakakibara Y, Inokuchi T, Kakimoto K, Yamada A, Yasuhara H, Yokoyama Y, Yoshino T, Matsui A, Nakamura M, Tomizawa T, Sakemi R, Kamata N, Hibi T.

Intest Res. 2018 Oct;16(4):609-618. doi: 10.5217/ir.2018.00044. Epub 2018 Oct 10.

37.

Evaluation of Pancreatic Fibrosis With Acoustic Radiation Force Impulse Imaging and Automated Quantification of Pancreatic Tissue Components.

Fujita Y, Kitago M, Abe T, Itano O, Shinoda M, Abe Y, Yagi H, Hibi T, Ishii M, Nakano Y, Okuma K, Hashimoto M, Takeuchi A, Masugi Y, Jinzaki M, Sakamoto M, Kitagawa Y.

Pancreas. 2018 Nov/Dec;47(10):1277-1282. doi: 10.1097/MPA.0000000000001179.

PMID:
30286012
38.

Advanced easySTED microscopy based on two-photon excitation by electrical modulations of light pulse wavefronts.

Otomo K, Hibi T, Fang YC, Hung JH, Tsutsumi M, Kawakami R, Yokoyama H, Nemoto T.

Biomed Opt Express. 2018 May 15;9(6):2671-2680. doi: 10.1364/BOE.9.002671. eCollection 2018 Jun 1.

39.

Efficacy and Safety of Dose Escalation to Adalimumab 80 mg Every Other Week in Japanese Patients with Crohn's Disease Who Lost Response to Maintenance Therapy.

Motoya S, Watanabe M, Wallace K, Lazar A, Nishimura Y, Ozawa M, Thakkar R, Robinson AM, Singh RSP, Mostafa NM, Suzuki Y, Hibi T.

Inflamm Intest Dis. 2018 Jul;2(4):228-235. doi: 10.1159/000486786. Epub 2018 May 15.

40.

Laparoscopic repeat liver resection after open liver resection: A comparative study from a single-centre.

Wakabayashi T, Abe Y, Itano O, Shinoda M, Kitago M, Yagi H, Hibi T, Oshima G, Minagawa T, Kitagawa Y.

J Minim Access Surg. 2018 Sep 3. doi: 10.4103/jmas.JMAS_175_18. [Epub ahead of print]

41.

Heterogeneous distribution of doublecortin-expressing cells surrounding the rostral migratory stream in the juvenile mouse.

Aoyagi Y, Hibi T, Kimori Y, Sawada M, Kawakami R, Sawamoto K, Nemoto T.

J Comp Neurol. 2018 Nov 1;526(16):2631-2646. doi: 10.1002/cne.24521. Epub 2018 Oct 23.

PMID:
30136724
42.

Infliximab for pediatric patients with Crohn's disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan.

Tajiri H, Motoya S, Kinjo F, Maemoto A, Matsumoto T, Sato N, Yamada H, Nagano M, Susuta Y, Ozaki K, Kondo K, Hibi T.

PLoS One. 2018 Aug 16;13(8):e0201956. doi: 10.1371/journal.pone.0201956. eCollection 2018.

43.

Corrigendum: Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies.

Motoya S, Watanabe M, Kim HJ, Kim YH, Han DS, Yuasa H, Tabira J, Isogawa N, Arai S, Kawaguchi I, Hibi T.

Intest Res. 2018 Jul;16(3):499-501. doi: 10.5217/ir.2018.16.3.499. Epub 2018 Jul 27.

44.

Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial.

Hisamatsu T, Kunisaki R, Nakamura S, Tsujikawa T, Hirai F, Nakase H, Watanabe K, Yokoyama K, Nagahori M, Kanai T, Naganuma M, Michimae H, Andoh A, Yamada A, Yokoyama T, Kamata N, Tanaka S, Suzuki Y, Hibi T, Watanabe M; CERISIER Trial group.

Intest Res. 2018 Jul;16(3):494-498. doi: 10.5217/ir.2018.16.3.494. Epub 2018 Jul 27. No abstract available.

45.

Successful EUS-guided nondilated pancreatic duct stent placement in patient with refractory pancreatic fistula after pancreaticoduodenectomy.

Minami K, Iwasaki E, Itoi T, Hibi T, Kanai T.

VideoGIE. 2017 Oct 12;2(11):315-316. doi: 10.1016/j.vgie.2017.07.012. eCollection 2017 Nov. No abstract available.

46.

Evolution of living donor liver transplantation: a global perspective.

Hibi T, Eguchi S, Egawa H.

J Hepatobiliary Pancreat Sci. 2018 Aug;25(8):388-389. doi: 10.1002/jhbp.571. No abstract available.

PMID:
29953731
47.

Histological Risk Factors to Predict Clinical Relapse in Ulcerative Colitis With Endoscopically Normal Mucosa.

Ozaki R, Kobayashi T, Okabayashi S, Nakano M, Morinaga S, Hara A, Ohbu M, Matsuoka K, Toyonaga T, Saito E, Hisamatsu T, Hibi T.

J Crohns Colitis. 2018 Nov 15;12(11):1288-1294. doi: 10.1093/ecco-jcc/jjy092.

PMID:
29939231
48.

Efficacy and Safety of Oral Budesonide in Patients with Active Crohn's Disease in Japan: A Multicenter, Double-Blind, Randomized, Parallel-Group Phase 3 Study.

Yokoyama T, Ohta A, Motoya S, Takazoe M, Yajima T, Date M, Nii M, Nagy P, Suzuki Y, Hibi T.

Inflamm Intest Dis. 2018 Mar;2(3):154-162. doi: 10.1159/000484047. Epub 2017 Nov 22.

49.

Tschimganine and its derivatives extend the chronological life span of yeast via activation of the Sty1 pathway.

Hibi T, Ohtsuka H, Shimasaki T, Inui S, Shibuya M, Tatsukawa H, Kanie K, Yamamoto Y, Aiba H.

Genes Cells. 2018 Jun 14. doi: 10.1111/gtc.12604. [Epub ahead of print]

50.

Establishment of a Novel Scoring System for Colon Capsule Endoscopy to Assess the Severity of Ulcerative Colitis-Capsule Scoring of Ulcerative Colitis.

Hosoe N, Nakano M, Takeuchi K, Endo Y, Matsuoka K, Abe T, Omori T, Hayashida M, Kobayashi T, Yoshida A, Mizuno S, Nakazato Y, Naganuma M, Kanai T, Watanabe M, Ueno F, Suzuki Y, Hibi T, Ogata H.

Inflamm Bowel Dis. 2018 Nov 29;24(12):2641-2647. doi: 10.1093/ibd/izy193.

PMID:
29846579

Supplemental Content

Support Center